151 related articles for article (PubMed ID: 28641880)
1. High effectiveness of repeated levosimendan cycles in a patient with advanced heart failure.
Rodríguez-Santamarta M; Sayago I; López J
Med Clin (Barc); 2017 Sep; 149(5):226. PubMed ID: 28641880
[No Abstract] [Full Text] [Related]
2. Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?
Dobarro D; Ribera-Solé A
Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):345-347. PubMed ID: 32107145
[No Abstract] [Full Text] [Related]
3. Effect of outpatient administration of levosimendan in reducing hospital readmission in patients with heart failure.
Acosta-Armas P; Medina-Gil JM; Martínez-Quintana E
Med Clin (Barc); 2023 Nov; 161(9):403-404. PubMed ID: 37598053
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
Comín-Colet J; Manito N; Segovia-Cubero J; Delgado J; García Pinilla JM; Almenar L; Crespo-Leiro MG; Sionis A; Blasco T; Pascual-Figal D; Gonzalez-Vilchez F; Lambert-Rodríguez JL; Grau M; Bruguera J;
Eur J Heart Fail; 2018 Jul; 20(7):1128-1136. PubMed ID: 29405611
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis.
Zhang X; Wang Z; Zhang L; Zhao X; Han Y
J Cardiovasc Pharmacol; 2024 Jul; 84(1):92-100. PubMed ID: 38547524
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan as bridge to transplant in patients with advanced heart failure.
Ponz de Antonio I; de Juan Bagudá JS; Rodríguez Chaverri A; García-Cosío Carmena MD; Arribas Ynsaurriaga F; Delgado Jiménez JF
Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):422-424. PubMed ID: 32061565
[No Abstract] [Full Text] [Related]
7. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.
Pölzl G; Allipour Birgani S; Comín-Colet J; Delgado JF; Fedele F; García-Gonzáles MJ; Gustafsson F; Masip J; Papp Z; Störk S; Ulmer H; Vrtovec B; Wikström G; Altenberger J
ESC Heart Fail; 2019 Feb; 6(1):174-181. PubMed ID: 30378288
[TBL] [Abstract][Full Text] [Related]
8. Intermittent levosimendan treatment for late onset right ventricular failure in a patient supported with a left ventricular assist device.
Yalcin YC; Caliskan K
Artif Organs; 2020 May; 44(5):533-534. PubMed ID: 31838742
[No Abstract] [Full Text] [Related]
9. Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy.
Sumanaru D; Josseran L; Essid A; Mbieleu B; Haegy I; Bergounioux J
Pediatr Cardiol; 2019 Mar; 40(3):668-670. PubMed ID: 30796500
[TBL] [Abstract][Full Text] [Related]
10. Decompensated congestive heart failure - treatment with levosimendan.
Buzzini RF; Silvinato A; Floriano I; Bernardo WM; Almeida GR
Rev Assoc Med Bras (1992); 2019 May; 65(4):524-529. PubMed ID: 31066804
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications.
Altenberger J; Gustafsson F; Harjola VP; Karason K; Kindgen-Milles D; Kivikko M; Malfatto G; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
J Cardiovasc Pharmacol; 2018 Mar; 71(3):129-136. PubMed ID: 28817484
[TBL] [Abstract][Full Text] [Related]
12. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain.
Manito Lorite N; Rubio-Rodríguez D; González Costello J; Díez López C; Enjuanes Grau C; Segovia-Cubero J; Delgado Jimenez JF; Campo Sien C; Rubio-Terrés C; Comín-Colet J; ;
Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):361-367. PubMed ID: 31899185
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.
Bouchez S; Fedele F; Giannakoulas G; Gustafsson F; Harjola VP; Karason K; Kivikko M; von Lewinski D; Oliva F; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
Cardiovasc Drugs Ther; 2018 Dec; 32(6):617-624. PubMed ID: 30402660
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan with other inotropes or vasopressors: Should you combine them?
Cunha GJL; Rocha BML; Gomes RV; Ferraz M; Fernandes L; Morais R; Campos L; Araújo I; Fonseca C
Am J Emerg Med; 2020 Dec; 38(12):2723-2726. PubMed ID: 32278570
[No Abstract] [Full Text] [Related]
15. Effects of levosimendan in heart failure: The role of echocardiography.
Cameli M; Incampo E; Navarri R; Mandoli GE; Sciaccaluga C; Righini FM; Palmerini E; Sisti N; Mondillo S; Lunghetti S
Echocardiography; 2019 Aug; 36(8):1566-1572. PubMed ID: 31287582
[TBL] [Abstract][Full Text] [Related]
16. Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Guerrero Orriach JL; Ramirez-Fernandez A; Escalona-Belmonte JJ; Rubio-Navarro M; Cruz-Manas J
Curr Vasc Pharmacol; 2018; 16(4):310-318. PubMed ID: 29149814
[TBL] [Abstract][Full Text] [Related]
17. Successful Combination of Landiolol and Levosimendan in Patients with Decompensated Heart Failure.
Dabrowski W; Siwicka-Gieroba D; Piasek E; Schlegel TT; Jaroszynski A
Int Heart J; 2020 Mar; 61(2):384-389. PubMed ID: 32132321
[TBL] [Abstract][Full Text] [Related]
18. A favorable alliance between repetitive use of levosimendan and advanced heart failure: Polish two-centered inpatient perspective in need of validation.
Książczyk M; Gruchała M; Stopczyńska I; Lelonek M
Kardiol Pol; 2023; 81(3):287-289. PubMed ID: 36739649
[No Abstract] [Full Text] [Related]
19. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan in Cardiac Surgery: Evaluating the Evidence.
Faisal SA; Apatov DA; Ramakrishna H; Weiner MM
J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1146-1158. PubMed ID: 30055988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
